Safety and Immunogenicity of Trivalent Subunit Inactivated Flu Vaccine Administered to Healthy Children and Adolescents 3 to 17 Years of Age

NCT01209780 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3116

Enrollment

INDUSTRY

Sponsor class

Conditions

Seasonal Influenza

Interventions

BIOLOGICAL: TIV
BIOLOGICAL: TIVf
BIOLOGICAL: Comparator TIV

Sponsor

Novartis Vaccines